The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Polymyxin B
Polymyxin B Sulfate · POLYMYXIN B SULFATE 500000 [USP'U]/1 · Injection, Powder, Lyophilized, For Solution · Intramuscular; Intrathecal; Intravenous · Sagent Pharmaceuticals
NDC 25021-0196-10 · 10 VIAL in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$149.50
Reported to Texas DSHS · 2026 annual filing · Sagent
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $103.78 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA207322
- TE code
- AP
- Approval date
- Apr 14, 2016
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Polymyxin B Sulfate (Injection, Powder, Lyophilized, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Fresenius Kabi USA, LLC | POLYMYXIN B SULFATE 500000 [USP'U]/1 | Jul 15, 2026 | Sep 3, 2026 |
| Fosun Pharma Usa Inc | POLYMYXIN B SULFATE 500000 [USP'U]/1 | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | POLYMYXIN B SULFATE 500000 [USP'U]/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | POLYMYXIN B SULFATE 500000 [USP'U]/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Polymyxin B — NDC 25021-0196-10," retrieved September 3, 2026, https://drugdashboards.com/drug/25021019610.
Free to cite with attribution — see how the data is put together.